To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06558604
Title A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or Relapsed/Refractory High-risk Mantle-cell Lymphoma (GLOASIS)
Acronym GLOASIS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Az Sint-Jan Brugge - Oostende Av RECRUITING Brugge Belgium Details
Institut Jules Bordet RECRUITING Brussel Belgium Details
Chu de Liege RECRUITING Liège Belgium Details
Chu Ucl Namur - Site Godinne RECRUITING Yvoir Belgium Details
Aphp - Hopital Henri Mondor RECRUITING Créteil France Details
Chu Dijon Bourgogne RECRUITING Dijon France Details
Chu de Lille - Hopital Claude Huriez RECRUITING Lille France Details
Institut Paoli Calmettes RECRUITING Marseille France Details
Chu de Montpellier RECRUITING Montpellier France Details
Chu de Nantes RECRUITING Nantes France Details
Chu Lyon-Sud RECRUITING Pierre-Bénite France Details
Chu de Reims - Hopital Robert Debre RECRUITING Reims France Details
Chu Pontchaillou RECRUITING Rennes France Details
Centre Henri Becquerel RECRUITING Rouen France Details
Institut Curie - Site Saint-Cloud RECRUITING Saint-Cloud France Details
Institut Curie RECRUITING Saint-Cloud France Details
Institut de Cancerologie Strasbourg Europe RECRUITING Strasbourg France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field